TCWM
ABVX

Total Clarity Wealth Management’s Abivax ABVX Stock Holding History

Total Clarity Wealth Management’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$825K Sell
7,410
-1,835
-20% -$217K 0.19% 127
2025
Q4 		$1.25M Buy
+9,245
New +$1.01M 0.3% 85

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

Total Clarity Wealth Management's ABVX Position: Q1 2026 in Review

Total Clarity Wealth Management reduced its Abivax (ABVX) stake by 20% in Q1 2026, selling an estimated $217K and leaving 7,410 shares worth $825K. The position accounts for 0.19% of the portfolio, ranked #127.

Total Clarity Wealth Management first reported a position in ABVX in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.25M in Q4 2025. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Total Clarity Wealth Management held 7,410 shares of Abivax worth $825K as of Q1 2026.
  • Total Clarity Wealth Management sold 1,835 Abivax shares in Q1 2026, an estimated $217K.
  • Abivax made up 0.19% of Total Clarity Wealth Management's portfolio in Q1 2026, its #127 holding.
  • Total Clarity Wealth Management first reported a position in Abivax in Q4 2025 and has held it in 2 quarters since.
  • Total Clarity Wealth Management's Abivax position peaked at $1.25M in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Total Clarity Wealth Management's 13F filing for Q1 2026, filed 17 Apr 2026.